A Phase I Study of GZR18 Injection in Obese/Overweight Subjects

Clinical trial NCT06548945 · COMPLETED

Trial details

NCT number: NCT06548945
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2023-04-25
Primary completion: 2023-08-14
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.